Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2008
12/11/2008WO2008148744A1 Thiadiazole derivatives as antidiabetic agents
12/11/2008WO2008148710A2 Aryloxazole, aryloxadiazole and benzimidazole derivatives as modulators of somatostatins receptor activity
12/11/2008WO2008148303A1 A composition for treating vegetative dystonine syndrome and pharmaceutical preparation and application thereof
12/11/2008WO2008148279A1 Cyclobutyl-fused pyrrolidine derivatives, their preparation methods and their medical use
12/11/2008WO2008148216A1 Drak2 expression is associated with diabetes
12/11/2008WO2008124522A3 Amylin formulations
12/11/2008WO2008111956A3 Fatty acid oxidation inhibitors treating hyperglycemia and related disorders
12/11/2008WO2007061661A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/11/2008US20080306275 Novel heteroaryl derivative
12/11/2008US20080306165 Compounds for the Treatment of Metabolic Disorders
12/11/2008US20080306157 Therapeutic intervention to MIMIC the effect of caloric restriction
12/11/2008US20080306156 Method of using catalpic acid to treat and prevent type 2 diabetes and associated disorders
12/11/2008US20080306150 Compounds for the Treatment of Metabolic Disorders
12/11/2008US20080306125 nuclear receptor modulators such as 6-{4-[3-(2,6-Dichloro-phenyl)-5-isopropyl-isoxazol-4-ylmethoxy]-phenyl}-1-isopropyl-1H-indole-3-carboxylic acid, used for treating dyslipidemia, atherosclerosis, diabetes, raising plasma high density lipoproteins, lowering low density lipoproteins and triglycerides
12/11/2008US20080306115 Midazole-4-Carboxamide Derivatives For Use As Cb1 Modulators
12/11/2008US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione
12/11/2008US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
12/11/2008US20080306102 Novel spirooxyindole compounds and drugs containing same
12/11/2008US20080306087 1-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-4-(2-nitro-phenylmethanesulfonyl)-piperazine; acylation or sulfonamidation of the piperazine ring; psychological disorders, Parkinson's, Alzheimer's, Huntington's Diseases; antidepressants, entiepileptics
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306059 Pyrimido [4,5-B] -Oxazines For Use as Dgat Inhibitors
12/11/2008US20080306055 Heterocyclic Mchr1 Antagonists And Their Use In Therapy
12/11/2008US20080306030 Use of a TRPM5 Inhibitor to Regulate Insulin and GLP-1 Release
12/11/2008US20080306011 Method of Controlling the Proliferation of Vascular Endothelial Cells and Inhibiting Lumen Formation
12/11/2008US20080306008 Peptides for Use in the Treatment of Obesity
12/11/2008US20080305998 appetite stimulants, antiobesity drugs, prolactin production inhibitors; drug screening; G-protein coupled (GPR)
12/11/2008US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
12/11/2008US20080305191 Drinking Water For a Diabetic and Manufacturing Process Thereof
12/11/2008US20080305190 Salvia hispanica I (Chia) in the management and treatment of cardiovascular disease, diabetes and associated risk factors
12/11/2008US20080305174 Polymeric nanocapsules for use in drug delivery
12/11/2008US20080305139 Pharmaceutical Compositions Comprising Dextran with a Molecular Weight of 1.0-100 Kda and Processes for Their Preparation
12/11/2008US20080305118 Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor
12/11/2008US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof
12/11/2008US20080305096 Method and composition for providing controlled delivery of biologically active substances
12/11/2008US20080305095 Nutritional Drink
12/11/2008US20080305090 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
12/11/2008DE102007026713A1 New 5-keto-D-fructose useful as medicaments, foodstuff e.g. marmalade, pasta, chocolate or sauces, sweetener, and for preparing products that are useful in the therapy of adiposity or diabetes
12/11/2008CA2698704A1 Novel compounds
12/11/2008CA2691446A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/11/2008CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
12/11/2008CA2689909A1 Long-acting polymeric prodrugs of exendin
12/11/2008CA2689641A1 Bloat controlling agent for a ruminant
12/11/2008CA2689604A1 Rumen fermentation improving agent
12/11/2008CA2689488A1 A method for modifying polyphenol containing plant materials and medical uses of modified polyphenol plant containing materials
12/11/2008CA2688594A1 Aryloxazole, aryloxadiazole and benzimidazole derivatives
12/11/2008CA2688493A1 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
12/11/2008CA2688136A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
12/11/2008CA2687912A1 Piperidine/piperazine derivatives
12/11/2008CA2687754A1 Piperidine/piperazine derivatives
12/11/2008CA2687243A1 Piperidine/piperazine derivatives
12/11/2008CA2600147A1 Combination for treatment of diabetes mellitus
12/10/2008EP2000469A2 Acylaminopiperidine compound
12/10/2008EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
12/10/2008EP2000461A1 Crystalline forms of atorvastatin
12/10/2008EP2000145A2 Ameliorating agent for metabolic syndrome
12/10/2008EP2000137A2 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
12/10/2008EP1999132A1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
12/10/2008EP1999098A2 Compounds that modulate ppar activity, their preparation and use
12/10/2008EP1998853A1 Healthy food product
12/10/2008EP1998768A2 Use of crf1 receptor antagonists for preparing a drug for treating metabolic syndrome and/or obesity and/or dyslipoproteinemia
12/10/2008EP1998637A1 Healthy food product
12/10/2008EP1863479B1 Tetrahydrothiopyrano pyrazole cannabinoid modulators cross reference to related applications
12/10/2008EP1720875B1 8- [3-amino-piperidin-1-yl]-xanthines, the production thereof, and the use of the same as medicaments
12/10/2008EP1675611B1 Therapeutic applications for c-peptide
12/10/2008EP1487410B1 Preparation of sterile stabilized nanodispersions
12/10/2008EP1274450B1 Medical uses of agonsist and antagonists of IL-174
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008CN101321761A Tricyclic amide derivatives useful for treating obesity
12/10/2008CN101321754A New compounds II
12/10/2008CN101321753A Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders
12/10/2008CN101321747A Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
12/10/2008CN101321743A L , l , 3-tri0x0-l , 2 , 5-thiadiaz0lidines and their use as PTP-ases inhibitors
12/10/2008CN101321531A Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
12/10/2008CN101321525A Heteroaryl substituted piperidine derivatives as L-CPT1 inhibitors
12/10/2008CN101319186A Preparation method for Chinese rose brandy for female
12/10/2008CN101318957A Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
12/10/2008CN101318956A Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
12/10/2008CN101318931A Diaryl substituted pyrazole derivative, preparation method and application thereof
12/10/2008CN101318925A Pyrrolidine-tetratomic ring derivants, preparation method and medical uses thereof
12/10/2008CN101318923A Crystalline forms of 'r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-'(phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid
12/10/2008CN101318922A Novel dipeptidyl peptidase restrainer, synthesizing process and uses thereof
12/10/2008CN101318889A Method of stabilizing reduced coenzyme Q10
12/10/2008CN101318021A Method for preparing composite vitamin beta-cyclodextrin clathrate compound
12/10/2008CN101317998A Medicament for treating hyperlipemia, fatty liver, liver damnification and preparation thereof
12/10/2008CN101317997A Preparation for effective component of turmeric
12/10/2008CN101317980A Radix pseudostellariae lysine tablet
12/10/2008CN101317978A Traditional Chinese medicine particle for rickets of children
12/10/2008CN101317977A Nourishing beverage particle for gestation period
12/10/2008CN101317957A Pharmaceutical composition for preventing birth defection and improving memory
12/10/2008CN101317956A Pharmaceutical composition for preventing birth defection and improving memory
12/10/2008CN101317955A Pharmaceutical composition for preventing birth defection and improving memory
12/10/2008CN101317947A Drinking particle for taking a tonic to build up health for confinement
12/10/2008CN101317925A Compound scabish effervescent tablet for slimming
12/10/2008CN101317907A Compound testis powder capsule of panax ginseng
12/10/2008CN101317898A Night plaster medicine for concurrent eye diseases of diabetes
12/10/2008CN101317871A Medicament composition for preventing birth defect and improving memory
12/10/2008CN101317870A Medicament composition for preventing birth defect and improving memory
12/10/2008CN101317869A Method for extracting flavone from capillary wormwood
12/10/2008CN101317850A Sucrose absorption inhibitor
12/10/2008CN101317828A Combination of capsule for preventing and controlling diabetes and preparation thereof
1 ... 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 ... 1298